What is NDC 64980-696?

64980-696 is the product NDC for Glipizide, Glipizide 5 mg/1 tablet, listed with the FDA by Rising Pharma Holdings, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Glipizide?

135 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Glipizide NDC 64980-696 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)64980-696Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64980-0696Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
64980-696-01	6498006960164980069601	100 TABLET in 1 BOTTLE (64980-696-01)Marketed from Oct 30, 2026
64980-696-10	6498006961064980069610	1000 TABLET in 1 BOTTLE (64980-696-10)Marketed from Oct 30, 2026
64980-696-50	6498006965064980069650	500 TABLET in 1 BOTTLE (64980-696-50)Marketed from Oct 30, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Glipizide
Generic name (nonproprietary): glipizide
Active ingredients: Glipizide — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Rising Pharma Holdings, Inc.NDC labeler code 64980
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219159
Marketing start: Oct 30, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Sulfonylurea Compounds (Chemical structure)
Identifiers: Product ID 64980-696_31a85319-fd49-49a6-a531-e7f456c774dfSPL ID 31a85319-fd49-49a6-a531-e7f456c774dfSPL set ID 82a5ea4b-4d1d-41e9-bb44-29c54d333411RxCUI 310488, 310490UNII X7WDT95N5C
Pharmacologic class: Sulfonylurea

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464980069601 followed by a unit qualifier and the quantity

Package 64980-0696-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 24, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Glipizide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 64980-696

What is NDC 64980-696?: 64980-696 is the product NDC for Glipizide, Glipizide 5 mg/1 tablet, listed with the FDA by Rising Pharma Holdings, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Glipizide.
What is the active ingredient?: Glipizide.
Who is the labeler?: Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Glipizide?: 135 other product NDCs are listed under this name. See all Glipizide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Glipizide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Glipizide	Glipizide 5 mg/1	TabletOral	AiPing Pharmaceutical, Inc.	11788-117	11788-0117-0111788-0117-0511788-0117-10
Glipizide	Glipizide 10 mg/1	TabletOral	AiPing Pharmaceutical, Inc.	11788-118	11788-0118-00
Glipizide	Glipizide 2.5 mg/1	TabletOral	AiPing Pharmaceutical, Inc.	11788-120	11788-0120-0111788-0120-0511788-0120-10
Glipizide	Glipizide 5 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-579	72789-0579-3072789-0579-6072789-0579-86+3 more
Glipizide	Glipizide 10 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-580	72789-0580-3072789-0580-6072789-0580-86+3 more
Glipizide	Glipizide 5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4178	68788-4178-0168788-4178-0368788-4178-06+2 more
Glipizide	Glipizide 10 mg/1	TabletOral	Coupler LLC	67046-0367	67046-0367-03
Glipizide	Glipizide 5 mg/1	TabletOral	Coupler LLC	67046-0236	67046-0236-03
Glipizide	Glipizide 10 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4061	68788-4061-0168788-4061-0368788-4061-06+2 more
Glipizide	Glipizide 10 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4017	68788-4017-0168788-4017-0368788-4017-06+2 more

All 136 Glipizide NDCs

Other NDCs under ANDA 219159

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219159
Product	Strength	Form · route	Labeler	Product NDC
Glipizide	Glipizide 10 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-697